Dr. Waxman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Boston, MA 02115Phone+1 617-525-9733Fax+1 617-264-6873- Is this information wrong?
Summary
- Dr. Aaron Waxman is a pulmonologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Faulkner Hospital and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 25 years. He specializes in critical care medicine, and pulmonary vascular medicine and is experienced in right-sided heart failure, pulmonary hypertension, pulmonary embolism, congestive heart failure, and pulmonary vascular disease.
Education & Training
- Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1994
- Yale-New Haven Medical CenterInternship, Internal Medicine, 1991 - 1992
- Yale School of MedicineClass of 1992
- Albany Medical CollegePh.D., Anatomy and Neuroscience, 1987
- George Washington UniversityB.S., Zoology, 1978
Certifications & Licensure
- MA State Medical License 1993 - 2026
- UT State Medical License 2009 - 2026
- FL State Medical License 2012 - 2021
- CT State Medical License 1994 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Best Doctors in Boston Boston Magazine, 2007, 2016, 2018-2024
- Distinguished Clinician Brigham and Women's Hospital, 2022
- Partners in Excellence Award Brigham and Women’s Hospital, 2014
- Join now to see all
Clinical Trials
- Protocolized Care for Early Septic Shock Start of enrollment: 2008 Mar 01
- Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2009 Jan 01
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension.Solaiappan Manimaran, Janethe de Oliveira Pena, Aaron B Waxman, David M Systrom, Jonathan Lu, Franz P Rischard> ;Circulation. Heart Failure. 2024 Apr 4
- Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCRE...Jason Weatherald, Steven D Nathan, Steven J Cassady, James Tarver, Deborah J Levine, Chunqin Deng, Eric Shen, Manisit Das, Karim El-Kersh, Rahul G Argula, Hilary M DuB...> ;BMJ Open Respiratory Research. 2024 Mar 22
- Automated CT-Based Quantification of Pulmonary Veins Shows Greater Central Venous Dilation in Group 2 Pulmonary Hypertension Compared With Group 1 Pulmonary Arterial H...Nardelli, P., Ross, J., San José Estépar, R., Synn, A., Harder, E., Maron, B., Leopold, J., Waxman, A., Washko, G., Rahaghi, F.> ;CHEST Pulmonary. 2023 Dec 1
- Join now to see all
Journal Articles
- Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertensionRahaghi, F.N., Ross, J.C., Agarwal, M., Gonzalez, G., Come, C.E., Diaz, A., Sanchez-Ferrero, G.V., Andetta, H., Jose Estapar, R.S., Waxman, A.B., Washko, G.R., Pulmonary Circulation, 1/1/2016
- Portopulmonary Hypertension, Challenges in Diagnosis and ManagementTroy P, Waxman AB, Therapeutic Advances in Gastroenterology, 1/1/2009
- Plasma Gelsolin is a Marker and Therapeutic Agent in Animal SepsisLee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP, Critical Care Medicine, 1/1/2007
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension...A.B. Waxman, V.F. Tapson, P.M. Smith, C.Q. Deng, S.D. Nathan, American Thoracic Society, San Diego, CA, 1/1/2018
- Ultrasound-assisted catheter-directed thrombolysis (UACDT) compared with anticoagulation alone for treatment of acute submassive pulmonary embolism.A.J. Schissler, R.J. Glynn, P.S. Sobieszczyk, A.B. Waxman, American Thoracic Society, San Diego, CA, 1/1/2018
- Right Ventricular-Pulmonary Arterial Uncoupling During Exercise in Pulmonary Hypertension.I. Singh, F. N. Rahaghi, M. Faria Urbina, R. K. Oliveira, T. Bachman, A. B. Waxman, D. M. Systrom, American Thoracic Society, San Diego, CA, 1/1/2018
- Join now to see all
Lectures
- What is new in Pulmonary Arterial Hypertension.Harvard Medical School and the Brigham and Women’s Hospital, Boston, MA - 1/1/2018
- Unexplained exertional intolerance: Dynamic assessment of cardiopulmonary and metabolic function during invasive exercise testing.Loma Linda, CA - 1/1/2018
- Treprostinil Administered Using a Fully Implantable Programmable Intravascular Delivery System.Intermountain Medical Center, Murray, UT - 1/1/2018
- Join now to see all
Other
- Approach to the patient with Dyspnea.Badr Eslam, R., Waxman, A.B., Scientific American Medicine, Pulmonary Medicine, Decker
https://www.deckerip.com/decker/scientific-american-medicine/chapter/115/
1/8/2016 - Advanced Prostanoid Therapy in PAH: The Time to Be Proactive Is Now!Waxman, AB, Chakinala, MM, Frantz, RP
http://www.medscape.org/viewarticle/755179
1/22/2011 - Diagnosis to Treatment: Facing the Challenges of Pulmonary Arterial Hypertension.Waxman AB, Clinical Case Challenge
1/1/2010 - Join now to see all
Press Mentions
- Pulmonary Hypertension Year in Review: Inhaled Therapy, Improving Mortality Trends in USJanuary 18th, 2022
- Why Am I so Tired After Working Out? It Could Be ‘Exercise Intolerance.’October 22nd, 2021
- Time from PAH Diagnosis Impacts Prognosis, Response to SelexipagAugust 5th, 2021
- Join now to see all
Grant Support
- IL-6 Type Cytokine Protection From Hyperoxic Lung InjuryNational Heart, Lung, And Blood Institute2004–2007
- Interleukin 11 Protection Hyperoxia Induced Lung InjuryNational Heart, Lung, And Blood Institute2001–2002
- Interleukin 11 Protection Hyperoxia Induced Lung InjuryNational Heart, Lung, And Blood Institute1999–2001
- Interleukin 11 Protection Hyperoxia Induced Lung InjuryNational Heart, Lung, And Blood Institute1998–1999
Hospital Affiliations
- Brigham and Women's Faulkner HospitalJamaica Plain, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
- Newton-Wellesley HospitalNewton Lower Falls, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: